Detection of blaIMP4 and blaNDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia

Emerging Health Threats Journal

Volumn 8, Issue 1, 2015, Pages

  Hamzan, Nurul Izzati ^a   Yean, Chan Yean ^a   Rahman, Rosliza Abdul ^a   Hasan, Habsah ^a   Rahman, Zaidah Abdul ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

carbapenem resistant enterobacteriaceae; Carbapenemase; Klebsiella pneumoniae; Modified hodge test

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLAIMP4 GENE; BLANDM1 GENE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFECT; GENE SEQUENCE; GENETIC ANALYSIS; KLEBSIELLA PNEUMONIAE; MALAYSIA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; ANTIBIOTIC RESISTANCE; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HUMAN; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; HOSPITALS, UNIVERSITY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALAYSIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING;

EID: 84930621591     PISSN: 17528550     EISSN: None     Source Type: Journal    
DOI: 10.3402/ehtj.v8.26011     Document Type: Article

References (29)

1. Kim SY, Park YJ, Yu JK, Kim HS, Park YS, Yoon JB, et al. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates. Diag Microb Infect Dis. 2007;57(1):85-91.
2. Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum b-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc. 2011;86(3):250-259.
3. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microb Infect. 2012; 18(1):54-60.
4. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47(6):1631-1639.
5. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010;54(5):2278-2279.
6. Lauderdale TL, Shi ZY, Lin CF, Lai JF, Tan MC, Wang JT, et al. KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan. Antimicrob Agents Chemother. 2012;56(4): 2207-2208.
7. Balm MND, Ngan G, Jureen R, Lin RTP, Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J Clin Microbiol. 2012;50(2): 475-476.
8. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? ClinMicrobiol Infect. 2011;17(8):1135-1141.
9. Keynan Y, Rubinstein E. The changing face of Klebsiella pneumoniae infections in the community. Int J Antimicrob Agents. 2007;30(5):385-389.
10. Balkhy HH, El-Saed A, Johani SM, Francis C, Al-Qahtani AA, Al-Ahdal MN, et al. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go? Euro J Clin Microbiol Infect Dis. 2012;31(8):1901-1909.
11. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
12. Amjad A, Mirza I, Abbasi S, Farwa U, Malik N, Zia F. Modified Hodge test: a simple and effective test for detection of carbapenemase production. Iran J Microbiol. 2011;3(4): 189-193.
13. Hung KH, Yan JJ, Lu JJ, Chen HM, Wu JJ. Characterization of the modified Hodge test-positive isolates of Enterobacteriaceae in Taiwan. J Microbiol Immunol Infect. 2013;46(1):35-40.
14. Queenan AM, Bush K. Carbapenemases: the versatile blactamases. Clin Microbiol Rev. 2007;20(3):440-458.
15. Aktas Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy. 2008;54(2):101-106.
16. Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011;55(11):5403-5407.
17. Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, et al. VIM-1 metallo-b-lactamaseproducing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol. 2003;41(8):3893-3896.
18. Jeanette T, My VL, Prabha K, Brend A, Roland J, Raymond TPL. Enterobacter cloacae producing an uncommon class A carbapenemase, IMI-1, from Singapore. J Med Microbiol. 2013;62:1086-1088.
19. Wang L, Gu H, Lu X. A rapid low-cost real-time PCR for the detection of Klebsiella pneumoniae carbapenemase genes. J Microbiol Methods. 2012;91(3):361-363.
20. Cantón R, Ruiz-Garbajosa P. Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol. 2011; 11(5):477-485.
21. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae. JAMA. 2008;300(24):2911-2913.
22. Kotlovsky T, Shalginov R, Austin L, Sprecher H. Rapid detection of positive Klebsiella pneumoniae in a clinical setting. Euro J Clin Microbiol Infect Dis. 2009;28(3):309-311.
23. Centers for Disease and Infection. Carbapenem-resistant Enterobacteriaceae (CRE). 2013. [cited 2013 Aug 28]. Available from: http://www.cdc.gov/HAI/organisms/cre/
24. Balm MND, Ngan G, Jureen R, Lin RP, Teo JWP. OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect Dis. 2013;13:58.
25. Hoang TH, Wertheim H, Minh NB, Duong TN, Anh DD, Phuong TTL, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing new Delhi metallobeta-lactamase isolated from two patients in Vietnam. J Clin Microbiol. 2013;51:373-374.
26. Chen PL, Ko WC. A continuous challenge from Gram-negative bacteria: more carbapenemases. J Microbiol Immunol Infect. 2010;43(5):351-353.
27. Guillermo VS, Ronald NM, Richard BC, Madiha F, Padmaraj D, Gupta J. Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010. Emerg Infect Dis. 2013;19(1): 133-136.
28. Karuniawati A, Saharman YR, Lestari DC. Detection of carbapenemase encoding genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumanii isolated from patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones. 2013;45(2):101-106.
29. National surveillance of antibiotic resistance report ministry of health, Malaysia 2012. [cited 2014 Jan 3]. Available from: http://www.imr.gov.my/images/uploads/NSAR/Summary-of-antibiotic-resistance-2012